Brief: Harvest One Cannabis Says Positive Results From Phase 2 Trials Using Satipharm Capsules
24/07/2018 14:14
July 24 (Reuters) - Harvest One Cannabis Inc HVT.V :
* POSITIVE FINAL RESULTS RETURNED FROM PHASE 2 CLINICAL
TRIALS
USING SATIPHARM CAPSULES
Source text for Eikon: ID:nCNWkxtrVa
Further company coverage: HVT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Delivra Health Brands
See all newsCanada's Delivra Health Q3 revenue plunges on Middle East disruptions
Cantor Equity Partners extends rally after 50% gain in previous session
Brief: Harvest One Reports C$4 Million Bought Deal Equity Unit Financing
Green dollar bills: Weed companies raise record cash as stocks rally
Brief: Harvest One Announces Management And Board Changes